REDHILL BIOPHARMA LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.375 USD | -4.56% |
|
-11.25% | -75.68% |
| 06-06 | RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board | CI |
| 05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-13 | 2024-06-14 | 2024-06-17 | 2024-06-18 | 2024-06-20 | |
|---|---|---|---|---|---|
| Last | 0.4 $ | 0.389201 $ | 0.3961 $ | 0.3929 $ | 0.355 $ |
| Volume | 200 463 | 329 844 | 274 854 | 1 639 614 | 322 379 |
| Change | -2.56% | -2.70% | +1.77% | -0.81% | -4.56% |
| Opening | 0.42 | 0.40 | 0.39 | 0.39 | 0.379 |
| High | 0.42 | 0.40 | 0.41 | 0.41 | 0.379 |
| Low | 0.39 | 0.38 | 0.37 | 0.37 | 0.3501 |
Performance
| 1 day | -9.65% | ||
| 1 week | -11.25% | ||
| Current month | -22.51% | ||
| 1 month | -22.83% | ||
| 3 months | -29.49% | ||
| 6 months | -74.64% | ||
| Current year | -75.68% | ||
| 1 year | -80.60% | ||
| 3 years | -99.87% | ||
| 5 years | -99.87% | ||
| 10 years | -99.95% |
Volumes
marketsDaily volume
322 379
Estimated daily volume
1 399 048
Avg. Volume 20 sessions
363 079
Daily volume ratio
3.85
Avg. Volume 20 sessions USD
136 154.63
Record volume 1
193 163 849
Record volume 2
155 052 530
Record volume 3
96 236 756
Capital turnover ratio
0.01
Float rotation
0.00
Basic data
Capitalization (USD)
12 520 541
Net sales (USD)
6 530 000
Number of employees
53
Sales / Employee (USD)
123 208
Free-Float
99 %
Free-Float capitalization (USD)
3 061 144 361
Average Daily Capital Traded
1.09%
Highs and lows
1 week
0.35
0.41
1 month
0.350.50
Current year
0.301.54
1 year
0.263.28
3 years
0.26447.20
5 years
0.26460.80
10 years
0.26888.80
Indicators
Moving average 5 days
0.40
Moving average 20 days
0.44
Moving average 50 days
0.45
Moving average 100 days
0.50
Price spread / (MMA5)
+6.05%
Price spread / (MMA20)
+18.48%
Price spread / (MMA50)
+18.85%
Price spread / (MMA100)
+32.00%
STIM
RSI 9 days
29.18
RSI 14 days
33.91
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -4.56% | -11.25% | -75.68% | -80.60% | 12.52M | ||
| -0.77% | +0.97% | +1.43% | +2.55% | 94.45B | ||
| +2.03% | +1.75% | -0.66% | -2.45% | 38.9B | ||
| -0.16% | -4.42% | -13.63% | -23.92% | 32.56B | ||
| +0.71% | +0.80% | -11.94% | -10.82% | 15.98B | ||
| -0.14% | -2.33% | -2.48% | -0.84% | 13.82B | ||
| -1.89% | -3.09% | -13.59% | -5.09% | 11.34B | ||
| -6.76% | -7.61% | +158.88% | +454.35% | 9.81B | ||
| -2.23% | -6.69% | -52.04% | -35.70% | 9.67B | ||
| +0.48% | +0.51% | +2.47% | +27.26% | 8.91B | ||
| +0.39% | +10.26% | +5.32% | +15.20% | 7.97B | ||
| -2.62% | +5.24% | -13.10% | +4.35% | 7.96B | ||
| +0.13% | +5.02% | -3.25% | 0.00% | 7.04B | ||
| -1.12% | -4.47% | -2.65% | +12.81% | 6.84B | ||
| +3.56% | -2.79% | -41.83% | -22.83% | 5.66B | ||
| -1.23% | -6.10% | -32.55% | +64.83% | 5.17B | ||
| Average | -1.19% | -0.00% | -5.96% | +24.94% | ||
| Weighted average by Cap. | -0.38% | +1.55% | -0.53% | +14.22% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
16c6a35dc67979aa09338e92f17.OhU2nfsI8vzm8-KfWPM4K4xGpoFkl5Zx0F2CcPgIFl4.fmBQ_4lYmpGgmYvlDpRhc7p-xc4H_9kBvGnsNZ9kbypYVkStkkvGydCQsw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 10:57:50 | 0.355 | 4,500 | 295,340 |
| 10:57:15 | 0.3672 | 1,000 | 290,840 |
| 10:56:49 | 0.3678 | 500 | 289,840 |
| 10:55:08 | 0.355 | 1,656 | 289,340 |
| 10:55:08 | 0.3584 | 200 | 287,684 |
| 10:55:08 | 0.3584 | 100 | 287,484 |
| 10:55:08 | 0.3584 | 100 | 287,384 |
| 10:55:08 | 0.3585 | 200 | 287,284 |
| 10:55:08 | 0.36 | 100 | 287,084 |
| 10:55:08 | 0.36 | 100 | 286,984 |
Monthly variations
Annual change
| 2024 | -73.09% | ||
| 2023 | -73.98% | ||
| 2022 | -94.56% | ||
| 2021 | -68.07% | ||
| 2020 | +33.11% | ||
| 2019 | +9.37% | ||
| 2018 | +7.98% | ||
| 2017 | -50.86% | ||
| 2016 | -18.79% | ||
| 2015 | -3.38% | ||
| 2014 | +12.97% | ||
| 2013 | +6.31% |
- Stock Market
- Equities
- RDHL Stock
- Quotes RedHill Biopharma Ltd.
